510(k) Report

510(k) · Cleared

Recalled · 2012

Dynasty Porous Acetabular Shell, Dynasty Polyethylene Acetabular Liner, Dynasty Metal Acetabular Liner

K082924510(k) SpecialCleared Mar 6, 2009156-day reviewClass III21 CFR 888.3330Recalls 17

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Wrightmedicaltechnologyinc · KWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)

Cleared on Mar 6, 2009 after a 156-day review. The FDA summary names no predicate by number. 25 later devices descend from it. It has been recalled 17 times.

Decided
Mar 6, 2009
Review
156 days
Class
Class III
Product code
KWA
Recalls
17
Predicates
0

25 later devices descend from it, 9 citing it directly.

Descendants, by year cleared 2011: 2 descendants cleared2012: 2 descendants cleared2021: 3 descendants cleared2017: 3 descendants cleared2018: 4 descendants cleared2024: 3 descendants cleared2020: 1 descendant cleared2022: 1 descendant cleared2019: 1 descendant cleared2025: 1 descendant cleared2026: 3 descendants cleared2023: 1 descendant cleared20052010201520202025
  1. This deviceK082924 Dynasty Porous Acetabular Shell, Dynasty Polyethylene Acetabular…Wrightmedicaltechnologyinc · 2009
  2. Descendant · cites it directly · 16 of its ownK170444 PROCOTYL® PRIME Acetabular Cup SystemMicroport Orthopedics, Inc. · 2017
  3. Descendant · cites it directly · 10 of its ownK171181 PROCOTYL® PRIME E-CLASS™ XLPE LinerMicroport Orthopedics, Inc. · 2017
  4. Descendant · 2 generations on · 5 of its ownK180263 EcoFit Vit E Acetabular SystemImplantcast GmbH · 2018
  5. Descendant · cites it directly · 5 of its ownK122382 Dynasty Biofoam ShellWrightmedicaltechnologyinc · 2012
  6. Descendant · cites it directly · 5 of its ownK111910 Gladiator Hip StemWrightmedicaltechnologyinc · 2011

Showing 5 of 25 descendants. See all descendants

Descendants cleared per year

2011: 22012: 22017: 32018: 42019: 12020: 12021: 32022: 12023: 12024: 32025: 12026: 3
2011high 4 (2018) · low 0 (2013)2026

Most influential descendants

Showing 5 of 25 · See all
  • K170444PROCOTYL® PRIME Acetabular Cup SystemMicroport Orthopedics, Inc. · 2017 · cites it directly16descendants
  • K171181PROCOTYL® PRIME E-CLASS™ XLPE LinerMicroport Orthopedics, Inc. · 2017 · cites it directly10descendants
  • K180263EcoFit Vit E Acetabular SystemImplantcast GmbH · 2018 · 2 generations on5descendants
  • K122382Dynasty Biofoam ShellWrightmedicaltechnologyinc · 2012 · cites it directly5descendants
  • K111910Gladiator Hip StemWrightmedicaltechnologyinc · 2011 · cites it directly5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K082924Dynasty Porous Acetabular Shell, Dynasty Polyethylene Acetabular Liner…Wrightmedicaltechnologyinc2009—
+1K170444PROCOTYL® PRIME Acetabular Cup SystemMicroport Orthopedics, Inc.2017—
+1K171181PROCOTYL® PRIME E-CLASS™ XLPE LinerMicroport Orthopedics, Inc.2017—
+2K180263EcoFit Vit E Acetabular SystemImplantcast GmbH2018—
+1K122382Dynasty Biofoam ShellWrightmedicaltechnologyinc2012—
+1K111910Gladiator Hip StemWrightmedicaltechnologyinc2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201120
201220
201730
201840
201910
202010
202130
202210
202310
202430
202510
202630
FIG. 1 — Lineage of K082924, 2009–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KWA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (25)

See all 25

9 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K170444PROCOTYL® PRIME Acetabular Cup SystemMicroport Orthopedics, Inc.201716
K171181PROCOTYL® PRIME E-CLASS™ XLPE LinerMicroport Orthopedics, Inc.201710
K122382Dynasty Biofoam ShellWrightmedicaltechnologyinc20125
K111910Gladiator Hip StemWrightmedicaltechnologyinc20115
K173898MicroPort Orthopedics Total Hip Systems MR LabelingMicroport Orthopedics Inc. (Mpo)20181
K201157Prime BIOFOAM® Multi-Hole ShellsMicroport Orthopedics, Inc.20210
K202705Prime and DYNASTY® Additive Manufacturing ShellsMicroport Orthopedics, Inc.20210
K121544Dynasty Biofoam ShellWrightmedicaltechnologyinc20120
K110029Conserve Bio Foam ShellWrightmedicaltechnologyinc20110

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 3, 2012Not classifiedZ-1022-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1017-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1020-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1021-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1026-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1027-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1018-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1019-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1016-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1023-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1024-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1025-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1028-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1029-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1030-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jan 3, 2012Not classifiedZ-1031-2012PackagingThe possibility exists that particulate debris from the packaging spacer could be unintentionally implanted into a patient and could potentially lead to complications that might necessitate a revision surgery.
Jun 7, 2010Not classifiedZ-2212-2010Software design (manufacturing process)The inner and outer product packaging was missing the following information: shelf life, translations, manufacturing date, CE marking and also listed the incorrect sterilization method.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K170444 (Microport Orthopedics, Inc., 2017) has gone furthest, with 16 descendants of its own.

How does its category compare?

All KWA devices

KWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component): FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · KWA

4in 2012

2007: 82008: 92009: 72010: 62011: 112012: 4
2007high 11 (2011) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KWA

76in 2012

2007: 74 days median2008: 57 days median2009: 139 days median2010: 167 days median2011: 101 days median2012: 76 days median
2007high 167 (2010) · low 57 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KWA

19in 2023

2008: 132010: 842011: 282012: 212013: 12016: 12017: 12018: 12019: 22020: 12023: 19
2007high 84 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KWA

1,216in 2025

2007: 2132008: 7622009: 8202010: 3,3482011: 17,7372012: 24,6012013: 20,0202014: 16,4942015: 12,3392016: 7,8722017: 6,8472018: 6,3882019: 7,6282020: 4,5382021: 2,0642022: 1,6172023: 1,4742024: 1,1682025: 1,216
2007high 24,601 (2012) · low 213 (2007)2025

MAUDE reports naming product code KWA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078740213
200895713762
200971390820
20106167843,348
2011111012817,737
20124762124,601
20130—120,020
20140—016,494
20150—012,339
20160—17,872
20170—16,847
20180—16,388
20190—27,628
20200—14,538
20210—02,064
20220—01,617
20230—191,474
20240—01,168
20250—01,216
20260—0—

What is it indicated for?

The DYNASTY® Acetabular System is indicated for use in total hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions: 1. non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli, and painful hip dysplasia; 2. inflammatory degenerative joint disease such as rheumatoid arthritis; 3. correction of functional…

Read the full statement (111 words)

The DYNASTY® Acetabular System is indicated for use in total hip arthroplasty for

reduction or relief of pain and/or improved hip function in skeletally mature patients with

the following conditions:

1. non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis,

ankylosis, protrusio acetabuli, and painful hip dysplasia;

2. inflammatory degenerative joint disease such as rheumatoid arthritis;

3. correction of functional deformity; and,

4. revision procedures where other treatments or devices have failed

The size 50 and 54mm ceramic femoral heads are only intended for patients with giganticism or

malunion of the acetabulum, and/or revision.

The DYNASTY® Acetabular Shell is for both cemented and uncemented use and is a single use

device.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082924: Dynasty Porous Acetabular Shell, Dynasty Polyethylene Acetabular Liner, Dynasty Metal Acetabular Liner.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K082924

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026